Edition:
United Kingdom

Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Global Market

0.72USD
23 May 2018
Change (% chg)

$0.02 (+3.29%)
Prev Close
$0.70
Open
$0.70
Day's High
$0.72
Day's Low
$0.70
Volume
16,358
Avg. Vol
65,577
52-wk High
$1.60
52-wk Low
$0.63

Chart for

About

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat a range of diseases. The Company uses its microRNA product platform to develop chemically modified, single-stranded oligonucleotides that the Company calls anti-miRs to modulate microRNAs and return... (more)

Overall

Beta: 1.65
Market Cap(Mil.): $142.19
Shares Outstanding(Mil.): 103.79
Dividend: --
Yield (%): --

Financials

  RGLS.OQ Industry Sector
P/E (TTM): -- 84.06 32.75
EPS (TTM): -1.53 -- --
ROI: -95.74 1.57 14.38
ROE: -149.70 2.43 16.07

BRIEF-Kathryn Collier Joins Regulus Board Of Directors

* KATHRYN J. COLLIER JOINS REGULUS BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

17 Apr 2018

BRIEF-Regulus Qtrly Net Loss Per Share $0.14

* REGULUS REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS AND PIPELINE UPDATE

07 Mar 2018

BRIEF-Regulus Therapeutics Files For Mixed Shelf Of Up To $150 Mln

* REGULUS THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $150 MILLION – SEC FILING‍​ Source text: (http://bit.ly/2rQDgcO) Further company coverage:

29 Jan 2018

Competitors

Earnings vs. Estimates